Top

Published in:

01-08-2019 | Osteoarthrosis | Observational Research

Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis

Authors: Benita Nancy Reni Michael, Vallayyachari Kommoju, Chengappa Kavadichanda Ganapathy, Vir Singh Negi

Published in: Rheumatology International | Issue 8/2019

Abstract

Microparticles (MP) are proposed to play a role in the pathogenesis of rheumatoid arthritis (RA). This study aimed to profile cell lineage-specific MP in patients with RA, osteoarthritis (OA), and healthy controls (HC) in synovial fluid and circulation. Patients with RA (n = 40), OA (n = 30) and HC (n = 33) were included. Cell-free synovial fluid (SF) and platelet-poor plasma samples were stained with annexin V APC and antibodies against CD45, CD20, CD14, CD4, CD8, CD66b, and CD61 for multicolor flow cytometry. Mann–Whitney U test/unpaired T test was used to assess intergroup differences among RA and OA SF and clinical, serological phenotypes of RA based on normality distribution; Kruskal–Wallis test with Dunn’s multiple comparisons for comparing plasma MPs among RA, OA, and HC. Correlation between MP proportions and disease parameters was assessed by Spearman’s correlation. The proportion of annexin V⁺ MP in SF of patients with RA [5 (6.35)] [median (IQR)] was higher compared to OA [1.8 (1.35), p < 0.001] and plasma of patients with RA [3.45 (5.63)] compared to OA [1.85 (1.4)] and HC [0.9 (1.1), p < 0.001]. Leukocyte-derived [0.85 (1.17)], granulocyte-derived [0.4 (2.05)], monocyte-derived [0.4 (0.4)], and T cell-derived MP [CD4⁺ – 0.1 (0.1); CD8⁺ − 0.1(0.1)] were higher in RA SF (p < 0.001). Platelet-derived MP (PMP) were the major fraction [1.5 (4.23), p < 0.001] in RA plasma. Leukocyte-derived MP were higher in RA plasma [0.1 (0.2); p < 0.001) than OA and HC. Annexin V⁺ MP and PMP were higher in the SF of RA with extra-articular manifestations (n = 15), as compared to those without (n = 25) (p = 0.02; p < 0.01, respectively). High SF granulocyte-derived MP were observed in patients with established RA (n = 24), ACPA-positive RA (n = 32) compared to their negative counterparts (p = 0.03; p = 0.02, respectively). Our observations of higher proportions of cell-derived MP in the plasma and synovial fluid of DMARD-naïve RA patients, their clinical and serological phenotypes suggest their role in dynamic cross talk between the joint and systemic circulation, disease pathology, and progression.

Available only for authorised users

Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388:2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8 CrossRefPubMed

Beyer C, Pisetsky DS (2010) The role of microparticles in the pathogenesis of rheumatic diseases. Nat Rev Rheumatol 6:21–29. https://doi.org/10.1038/nrrheum.2009.229 CrossRefPubMed

Pisetsky DS, Ullal AJ, Gauley J, Ning TC (2012) Microparticles as mediators and biomarkers of rheumatic disease. Rheumatol (United Kingdom) 51:1737–1746. https://doi.org/10.1093/rheumatology/kes028 CrossRef

Willms A, Müller C, Julich H et al (2014) Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia. Oncotarget 7:30867–30875. https://doi.org/10.18632/oncotarget.9018 CrossRef

Buzas EI, György B, Nagy G et al (2014) Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol 10:356–364. https://doi.org/10.1038/nrrheum.2014.19 CrossRefPubMed

Withrow J, Murphy C, Liu Y et al (2016) Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 18:1–12. https://doi.org/10.1186/s13075-016-1178-8 CrossRef

Horstman LL, Jy W, Jimenez JJ et al (2004) New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53:210–230CrossRefPubMed

Sellam J, Proulle V, Jüngel A et al (2009) Increased levels of circulating microparticles in primary Sjögren’s syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 11:R156. https://doi.org/10.1186/ar2833 CrossRefPubMedPubMedCentral

Pereira J, Alfaro G, Goycoolea M et al (2006) Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 95:94–99CrossRefPubMed

10.

Niccolai E, Squatrito D, Emmi G et al (2015) A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies. Thromb Res 136:1252–1258. https://doi.org/10.1016/j.thromres.2015.10.018 CrossRefPubMed

11.

Knijff-Dutmer EAJ, Koerts J, Nieuwland R et al (2002) Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum 46:1498–1503. https://doi.org/10.1002/art.10312 CrossRefPubMed

12.

Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP et al (2011) Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 31:153–164. https://doi.org/10.1007/s00296-010-1446-x CrossRefPubMed

13.

Berckmans RJ, Nieuwland R, Tak PP et al (2002) Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum 46:2857–2866. https://doi.org/10.1002/art.10587 CrossRefPubMed

14.

Cai Z, Zhang W, Yang F et al (2012) Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell Res 22:607–610. https://doi.org/10.1038/cr.2011.196 CrossRefPubMed

15.

Michael BR, Misra D, Chengappa K, Negi V (2018) Relevance of elevated microparticles in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Indian J Rheumatol 13:222. https://doi.org/10.4103/injr.injr_101_18 CrossRef

16.

Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581. https://doi.org/10.1002/art.27584 CrossRefPubMed

17.

Carlson RV, Boyd KM, Webb DJ (2004) The revision of the Declaration of Helsinki: past, present and future. Br J Clin Pharmacol 57:695–713. https://doi.org/10.1111/j.1365-2125.2004.02103.x CrossRefPubMedPubMedCentral

18.

Nielsen CT, Østergaard O, Stener L et al (2012) Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum 64:1227–1236. https://doi.org/10.1002/art.34381 CrossRefPubMed

19.

20.

Anderson J, Caplan L, Yazdany J et al (2012) Rheumatoid arthritis disease activity measures: American college of rheumatology recommendations for use in clinical practice. Arthritis Care Res 64:640–647. https://doi.org/10.1002/acr.21649 CrossRef

21.

Man Q, Zhang L, Zhao Y et al (2018) Lymphocyte-derived microparticles stimulate osteoclastogenesis by inducing RANKL in fibroblasts of odontogenic keratocysts. Oncol Rep 40:3335–3345. https://doi.org/10.3892/or.2018.6708 CrossRefPubMed

22.

Kim H-R, Mun Y, Lee K-S et al (2018) T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun 9:3630. https://doi.org/10.1038/s41467-018-06090-8 CrossRefPubMedPubMedCentral

23.

Angelillo-Scherrer A (2012) Leukocyte-derived microparticles in vascular homeostasis. Circ Res 110:356–369. https://doi.org/10.1161/CIRCRESAHA.110.233403 CrossRefPubMed

24.

Guervilly C, Lacroix R, Forel J-M et al (2011) High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome. Crit Care 15:R31. https://doi.org/10.1186/cc9978 CrossRefPubMedPubMedCentral

25.

Distler JHW, Jungel A, Huber LC et al (2005) The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci 102:2892–2897. https://doi.org/10.1073/pnas.0409781102 CrossRefPubMedPubMedCentral

26.

Berckmans RJ, Nieuwland R, Kraan MC et al (2005) Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res Ther 7:R536–R544. https://doi.org/10.1186/ar1706 CrossRefPubMedPubMedCentral

27.

Messer L, Alsaleh G, Freyssinet JM et al (2009) Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes. Arthritis Res Ther 11:1–10. https://doi.org/10.1186/ar2648 CrossRef

28.

Va Biró E, Nieuwland R, Tak PP et al (2007) Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individuals. Ann Rheum Dis 66:1085–1092. https://doi.org/10.1136/ard.2006.061309 CrossRef

29.

Reich N, Beyer C, Gelse K et al (2011) Microparticles stimulate angiogenesis by inducing ELR + CXC-chemokines in synovial fibroblasts. J Cell Mol Med 15:756–762. https://doi.org/10.1111/j.1582-4934.2010.01051.x CrossRefPubMed

30.

Jüngel A, Distler O, Schulze-Horsel U et al (2007) Microparticles stimulate the synthesis of prostaglandin E2 via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum 56:3564–3574. https://doi.org/10.1002/art.22980 CrossRefPubMed

31.

Greisen SR, Yan Y, Hansen AS et al (2017) Extracellular vesicles transfer the receptor programmed death-1 in rheumatoid arthritis. Front Immunol 8:851. https://doi.org/10.3389/fimmu.2017.00851 CrossRefPubMedPubMedCentral

32.

Polanco JC, Scicluna BJ, Hill AF, Götz J (2016) Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner. J Biol Chem 291:12445–12466. https://doi.org/10.1074/jbc.M115.709485 CrossRefPubMedPubMedCentral

33.

Wang W, Liu J, Yang B et al (2017) Modulation of platelet-derived microparticles to adhesion and motility of human rheumatoid arthritis fibroblast-like synoviocytes. PLoS One 12:e0181003. https://doi.org/10.1371/journal.pone.0181003 CrossRefPubMedPubMedCentral

34.

Foulquier C, Sebbag M, Clavel C et al (2007) Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 56:3541–3553. https://doi.org/10.1002/art.22983 CrossRefPubMed

35.

Wright HL, Moots RJ, Bucknall RC, Edwards SW (2010) Neutrophil function in inflammation and inflammatory diseases. Rheumatology 49:1618–1631. https://doi.org/10.1093/rheumatology/keq045 CrossRefPubMed

36.

Spengler J, Lugonja B, Jimmy Ytterberg A et al (2015) Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol 67:3135–3145. https://doi.org/10.1002/art.39313 CrossRefPubMedPubMedCentral

37.

Corsiero E, Pratesi F, Prediletto E et al (2016) NETosis as source of autoantigens in rheumatoid arthritis. Front Immunol 7:485. https://doi.org/10.3389/fimmu.2016.00485 CrossRefPubMedPubMedCentral

38.

Cloutier N, Tan S, Boudreau LH et al (2013) The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med 5:235–249. https://doi.org/10.1002/emmm.201201846 CrossRefPubMed

39.

Burbano C, Rojas M, Muñoz-Vahos C et al (2018) Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis. Sci Rep. https://doi.org/10.1038/s41598-018-36335-x CrossRefPubMedPubMedCentral

40.

Pisetsky DS, Lipsky PE (2010) Microparticles as autoadjuvants in the pathogenesis of SLE. Nat Rev Rheumatol 6:368–372. https://doi.org/10.1038/nrrheum.2010.66 CrossRefPubMed

41.

Burnier L, Fontana P, Kwak BR, Angelillo-Scherrer A (2009) Cell-derived microparticles in haemostasis and vascular medicine. Thromb Haemost 101:439–451CrossRefPubMed

42.

Boilard E, Nigrovic PA, Larabee K et al (2010) Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327:580–583. https://doi.org/10.1126/science.1181928 CrossRefPubMedPubMedCentral

43.

Barry OP, Pratico D, Lawson JA, FitzGerald GA (1997) Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 99:2118–2127. https://doi.org/10.1172/JCI119385 CrossRefPubMedPubMedCentral

44.

45.

Barry OP, Praticò D, Savani RC, FitzGerald GA (1998) Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 102:136–144. https://doi.org/10.1172/JCI2592 CrossRefPubMedPubMedCentral

46.

Forlow SB, McEver RP, Nollert MU (2000) Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 95:1317–1323PubMed

47.

del Conde I, Shrimpton CN, Thiagarajan P, López JA (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106:1604–1611. https://doi.org/10.1182/blood-2004-03-1095 CrossRefPubMed

48.

49.

Wang F, Wang N-S, Yan C-G et al (2007) The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 26:768–771. https://doi.org/10.1007/s10067-007-0550-0 CrossRefPubMed

50.

Maugeri N, Franchini S, Campana L et al (2012) Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity 45:584–587. https://doi.org/10.3109/08916934.2012.719946 CrossRefPubMed

51.

Lood C, Tydén H, Gullstrand B et al (2016) Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus. Rheumatology 56:kew437. https://doi.org/10.1093/rheumatology/kew437 CrossRef

52.

Arraud N, Gounou C, Turpin D, Brisson AR (2016) Fluorescence triggering: a general strategy for enumerating and phenotyping extracellular vesicles by flow cytometry. Cytom Part A 89:184–195. https://doi.org/10.1002/cyto.a.22669 CrossRef

53.

54.

55.

Messer L, Alsaleh G, Freyssinet J-M et al (2009) Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes. Arthritis Res Ther 11:R40. https://doi.org/10.1186/ar2648 CrossRefPubMedPubMedCentral

56.

Umekita K, Hidaka T, Ueno S et al (2009) Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritis. Mod Rheumatol 19:265–272. https://doi.org/10.3109/s10165-009-0164-2 CrossRefPubMed

57.

György B, Szabó TG, Turiák L et al (2012) Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases. PLoS One 7:e49726. https://doi.org/10.1371/journal.pone.0049726 CrossRefPubMedPubMedCentral

58.

Rodríguez-Carrio J, Alperi-López M, López P et al (2015) Altered profile of circulating microparticles in rheumatoid arthritis patients. Clin Sci 128:437–448. https://doi.org/10.1042/CS20140675 CrossRef

59.

Viñuela-Berni V, Doníz-Padilla L, Figueroa-Vega N et al (2015) Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease. Clin Exp Immunol 180:442–451. https://doi.org/10.1111/cei.12598 CrossRefPubMedPubMedCentral

60.

Fan W, Wang W, Wu J et al (2017) Identification of CD4 ⁺ T-cell-derived CD161 ⁺ CD39 ⁺ and CD39 ⁺ CD73 ⁺ microparticles as new biomarkers for rheumatoid arthritis. Biomark Med 11:107–116. https://doi.org/10.2217/bmm-2016-0261 CrossRefPubMed

Title: Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis
Authors: Benita Nancy Reni Michael
Vallayyachari Kommoju
Chengappa Kavadichanda Ganapathy
Vir Singh Negi
Publication date: 01-08-2019
Publisher: Springer Berlin Heidelberg
Keywords: Osteoarthrosis
Osteoarthrosis
Rheumatoid Arthritis
Published in: Rheumatology International / Issue 8/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-019-04337-1

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2019

Clinical use of anti-DFS70 autoantibodies

Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological findings

Rheumatology training and research in Iran

Correction to: Systemic vasculitis involving the breast: a case report and literature review